Clinical Trials Sponsored by Xiamen University

Total 221824 results

Xiamen Innovax Biotech Co., Ltd

Completed

Immunogenicity and Safety of One Dose of HPV Vaccine

Human Papillomavirus Vaccines

China
Xiamen LP Pharmaceutical Co., Ltd

Completed

Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting

Nausea With Vomiting Chemotherapy-Induced

United States
Xiamen Innovax Biotech Co., Ltd

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients )

Hepatitis E

China
Xiamen Amoytop Biotech Co., Ltd.

Completed

Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C Patients

Chronic Hepatitis C

China
Xiamen Innovax Biotech Co., Ltd

Completed

A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)

Hepatitis E

China
Xiamen Amoytop Biotech Co., Ltd.

Completed

Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy

Breast Cancer | Non Small Cell Lung Cancer

China
Xiamen Innovax Biotech Co., Ltd

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)

Hepatitis B | Hepatitis E

China
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age

Cervical Cancer | Condylomata Acuminata

China
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Active, not recruiting

Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Cervical Cancer | Cervical Intraepithelial Neoplasia | Condylomata Acuminata

China
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Cervical Cancer | Condylomata Acuminata

China
Xiamen University
Xiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...

Completed

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Cervical Cancer | Condylomata Acuminata

China
Xiamen Innovax Biotech Co., Ltd
Xiamen University; Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)

Hepatitis E

China
The First Affiliated Hospital of Xiamen University

Recruiting

Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression

Refractory Solid Tumor

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Dexmedetomidine Premedication for Post-anaesthesia Sleep Disturbance

Postoperative Sleep Disturbance
The First Affiliated Hospital of Xiamen University

Recruiting

Mobile Internet Healthcare and Three Disciplines Co-management Intervention for Overweight/Obese Prediabetic Patients

Prediabetes | Weight Management | Overweight/Obesity

China
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT

Ankylosing Spondylitis | Spondyloarthritis | Axial Spondyloarthritis

China
The First Affiliated Hospital of Xiamen University

Recruiting

Clinical Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Various Solid Tumors

Refractory Solid Tumor

China
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG

Positron-Emission Tomography | FAP | SSTR2

China
The First Affiliated Hospital of Xiamen University

Recruiting

A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer

Ovarian Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

Evaluatioon of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors

SSTR2-positive Tumors

China
The First Affiliated Hospital of Xiamen University

Recruiting

PET Imaging of LAG-3 Expression

Tumor, Solid

China
The First Affiliated Hospital of Xiamen University

Recruiting

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

Colorectal Neoplasms

China
The First Affiliated Hospital of Xiamen University

Recruiting

A Single-Arm Phase II Clinical Study of Pemigatinib in the Treatment of Advanced Non-Small Cell Lung Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy

Advanced Non-Small Cell Lung Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-DOTA-FAPI and 177Lu-DOTA-FAPI Theranostic Pair in Patients With Various Types of Cancer (Locally Advanced or Metastatic Cancer)

177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | Theranostic

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer

Multiple Primary Lung Cancer
The First Affiliated Hospital of Xiamen University

Recruiting

Diabetic Complications and Obstructive Sleep Apnea (DMOS)

Diabetic Complications and Obstructive Sleep Apnea

China
The First Affiliated Hospital of Xiamen University

Recruiting

Time Restricted Feeding on Impaired Glucose Regulation(TRIG Trial) (TRIG)

Impaired Glucose Regulation | Time-Restricted Feeding | Overweight/Obese

China
The First Affiliated Hospital of Xiamen University

Completed

APA on Sleep Quality in Women With PCOS

Polycystic Ovary Syndrome

China
The First Affiliated Hospital of Xiamen University

Completed

Time-Restricted Feeding(TRF) on Overweight/Obese Women With Polycystic Ovarian Syndrome (PCOS) (TRF-PCOS)

Overweight and Obesity | Polycystic Ovary Syndrome (PCOS)

China
The First Affiliated Hospital of Xiamen University

Completed

Comaprison of 68Ga-FAP-2286 and 18F-FDG PET/CT in Patients With Various Types of Cancer

Positron-Emission Tomography | Tumor, Solid

China
The First Affiliated Hospital of Xiamen University

Active, not recruiting

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Non-small Cell Lung Cancer Stage IV

China
The First Affiliated Hospital of Xiamen University

Unknown

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

Lung Adenocarcinoma | PET/CT | 18F-FDG | 68Ga-FAPI

China
The First Affiliated Hospital of Xiamen University

Unknown

Triplezumab Combined With CAPEOX Regimen in Neoadjuvant Therapy for Locally Advanced Colon Cancer

Locally Advanced Colon Cancer

China
West China Hospital
Xiamen Health Commission; Xiamen Health and Medical Big Data Center

Completed

A Population-based Study of Drug Exposures and Adverse Pregnancy Outcomes in China (DEEP)

Pregnancy | Congenital Malformation | Drug Exposure

China
Kylonova (Xiamen) Biopharma co., LTD.

Recruiting

Dose Escalation Study of Kylo-0603 in Healthy Subjects

Nonalcoholic Steatohepatitis

China
Xiamen LP Pharmaceutical Co., Ltd

Recruiting

Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC

Chemotherapy-induced Nausea and Vomiting

United States
Xiamen Amoytop Biotech Co., Ltd.

Completed

PK & PD Study of Pegylated rhEPO, and Evaluated Its Safety and Tolerability in Male Healthy Individual

Healthy

China
Xiamen Amoytop Biotech Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Assessment of Ypeginterferon Alfa-2a in Healthy Subjects

Healthy Subjects

China
The First Affiliated Hospital of Xiamen University

Recruiting

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) (SEGNO)

Oligometastatic Prostate Cancer | Locally Advanced Prostate Cancer

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery

Pituitary Neoplasms
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Maintenance Therapy After Platinum-containing Chemotherapy in Patients With Recurrent Ovarian Cancer

Ovarian Cancer
The First Affiliated Hospital of Xiamen University

Recruiting

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.

Primary Myelofibrosis

China
The First Affiliated Hospital of Xiamen University

Recruiting

Characterizing Myositis With 68Ga-FAPI PET/CT

Myositis | Idiopathic Inflammatory Myopathies

China
The First Affiliated Hospital of Xiamen University

Recruiting

Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)

AF - Atrial Fibrillation | HTN-Hypertension

China
The First Affiliated Hospital of Xiamen University

Recruiting

Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients (LORMYF)

Rheumatoid Arthritis

China
The First Affiliated Hospital of Xiamen University

Recruiting

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Refractory Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell Carcinoma

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Prevention In Community Clinics From Diabetic Kidney Disease (PICK)

Diabetic Nephropathies
Endofotonics Pte Ltd
Zhongshan Hospital Xiamen University

Recruiting

Evaluating Diagnostic Performance of Spectra IMDx System for Detection of Gastric Cancer and Precancerous Lesions

Gastric Cancer | Gastric Precancerous Lesion

China
The First Affiliated Hospital of Xiamen University

Not yet recruiting

Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC

Lung Neoplasms
The First Affiliated Hospital of Xiamen University

Recruiting

A Nurse Cohort Study in Xiamen, China

Hypertension

China

Clinical Trials Sponsored by Xiamen University

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations